America's Growth Capital and Bryan, Garnier & Co Announce Joint Venture.

Firms enter partnership to expand transatlantic service offering and join forces on deal sourcing

BOSTON & LONDON -- America's Growth Capital, an emerging growth-focused, research, trading and investment banking partnership with its footprint in the U.S., and Bryan, Garnier & Co ("Bryan Garnier"), an independent pan-European investment bank focused on European growth companies, announced today that they have entered into a joint venture. The companies will combine forces on lead generation and transaction sourcing in order to complement each other's strengths and areas of focus.

"Bryan Garnier is a firm that shares our commitment in the emerging growth markets to bringing senior-level dedication and attention to each client," said Ben Howe, chief executive officer of America's Growth Capital. "This partnership makes a lot of sense for us, as they are trying to capture and bring us in on deals that we would never see and that they wouldn't likely win without our credentials and transaction history."

"America's Growth Capital has an exceptional track record in technology markets; we strongly believe that the combination with Bryan Garnier's capabilities will deliver a unique value for our European technology clients, looking for US acquisitions", said Bruno Tourme, head of Bryan Garnier's Corporate Finance Technology Group.

About America's Growth Capital:

America's Growth Capital is a full-service, boutique investment bank with offices in Boston, MA and San Francisco, CA. The firm's 62 transactions since inception (August, 2003) have ranged in size from $6 million to $1 billion and have included buyouts, buy-side and sell-side advisory assignments (including cross-border transactions), PIPEs, IPOs, Follow-ons, private placements and fairness opinions. AGC's core industry focus areas include technology, business services, digital media, Internet and healthcare. America's Growth Capital is a member of FINRA and SIPC.

AGC's recent notable transactions include:

* Sole placement agent of $17 million clean tech financing for ConsumerPowerline;

* Financial advisor to NetScout in $205 million acquisition of Network General;

* Sole advisor to SilverBack Technologies in sale to Dell;

* Sole advisor to Seagull Software in $60 million cross-border sale to Rocket Software;

* Sole advisor to CipherTrust in $282 million sale to Secure Computing;

* Sole advisor to Counterpane Internet Security in sale to British Telecommunications;

* Advisor to BindView in $210 million sale to Symantec;

* Sole placement agent of $8.5 million PIPE for GlobalSCAPE.

About Bryan Garnier:

Bryan, Garnier & Co is an independent pan-European investment bank focused on growth companies in Technology, Media & Telecom, Health & Life Sciences and Renewable Energies. With a research-driven approach, Bryan, Garnier & Co offers institutional sales and trading, asset management and corporate finance services to growth oriented investors and companies.

With 85 professionals based in London, Paris and Geneva, Bryan, Garnier & Co offers the expertise of a full-fledged investment bank with the personalized attention and long-term client relationships of a boutique investment bank.

Bryan, Garnier & Co Corporate Finance practice advises European public and private growth companies, entrepreneurs and investors through:

* Equity Capital Markets

* Private Placements

* Mergers & Acquisitions

Bryan, Garnier & Co Ltd is authorized and regulated by the FSA, and a member of LSE and NYSE EURONEXT.

Most recently, Bryan Garnier has been leading the following transactions:

* Lead manager and Book runner of a EU54 million capital raising for Risc Group (RSC)

* Sole manager of a EU 40 million capital increase for Bioalliance (BIO)

* Sole manager of a EU 12 million IPO for Orolia (ALORO)

* Lead manager and Book runner of a EU100 million capital increase for Transgene (TSG)